COVID-19 Impact Assessment for Cancer Patients
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand how the COVID-19 pandemic has affected the quality of life and mental well-being of individuals with a history of cancer. Participants will complete a survey about their experiences during the pandemic, focusing on areas such as health care disruptions and social interactions. The information gathered will aid in creating programs to better support cancer patients and survivors during global crises. Individuals who previously participated in certain cancer studies and have an active email address or MyChart access may be eligible to join this trial. As an unphased trial, this study offers participants a valuable opportunity to contribute to meaningful research that could enhance support systems for cancer patients during future global crises.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems to focus on questionnaires about experiences during the COVID-19 pandemic, so it's unlikely that medication changes are required.
Why are researchers excited about this trial?
Researchers are excited about this trial because it focuses on understanding how the COVID-19 pandemic has impacted the quality of life in cancer patients and survivors. Unlike traditional clinical trials that test new medications or therapies, this trial uses surveys to gather real-world insights directly from participants about their pandemic experiences. This approach can reveal crucial information about mental, emotional, and social factors affecting cancer patients, offering a comprehensive view that standard medical treatments may not address. By identifying these unique challenges, researchers hope to improve support systems and quality of life strategies for cancer patients and survivors in future crises.
Who Is on the Research Team?
Lorenzo Cohen
Principal Investigator
M.D. Anderson Cancer Center
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Survey Completion
Participants complete a survey online over 35-45 minutes about their experiences regarding the COVID-19 pandemic
Follow-up
Participants are monitored for any changes in psychological distress and HRQoL after survey completion
What Are the Treatments Tested in This Trial?
Interventions
- Quality-of-Life Assessment
- Questionnaire Administration
- Survey Administration
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Participants complete a survey online over 35-45 minutes about their experiences regarding the COVID-19 pandemic.
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.